Reduction of Influenza Virus Titer and Protection Against Influenza Virus Infection in Infant Mice Fed Lactobacillus Casei Shirota

Overview

Journal Clin Diagn Lab Immunol

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2004 Jul 10

PMID 15242940

Citations 64

Authors

Hisako Yasui

Junko Kiyoshima

Tetsuji Hori

Affiliations

Soon will be listed here.

Abstract

We investigated whether oral administration of Lactobacillus casei strain Shirota to neonatal and infant mice ameliorates influenza virus (IFV) infection in the upper respiratory tract and protects against influenza infection. In a model of upper respiratory IFV infection, the titer of virus in the nasal washings of infant mice administered L. casei Shirota (L. casei Shirota group) was significantly (P < 0.05) lower than that in infant mice administered saline (control group) (10(2.48) +/- 10(0.31) and 10(2.78) +/- 10(0.4), respectively). Further, the survival rate of the L. casei Shirota group was significantly (P < 0.05) higher than that of the control group (14.3 versus 40.0%). One day after infection, pulmonary NK cell activity and interleukin-12 production by mediastinal lymph node cells of mice in the L. casei Shirota group were significantly greater than those of mice in the control group. These findings suggest that oral administration of L. casei Shirota activates the immature immune system of neonatal and infant mice and protects against IFV infection. Therefore, oral administration of L. casei Shirota may accelerate the innate immune response of the respiratory tract and protect against various respiratory infections in neonates, infants, and children, a high risk group for viral and bacterial infections.

Citing Articles

Renal protective and immunoregulatory effects of strain Shirota in nephropathy-prone mice.

Chan C, Chen Y, Lin B Front Nutr. 2024; 11:1438327.

PMID: 39262432 PMC: 11389617. DOI: 10.3389/fnut.2024.1438327.

Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition.

Abenavoli L, Scarpellini E, Paravati M, Scarlata G, Boccuto L, Tilocca B Nutrients. 2023; 15(16).

PMID: 37630759 PMC: 10459644. DOI: 10.3390/nu15163569.

Identification of novel lactic acid bacteria with enhanced protective effects against influenza virus.

Sugimoto A, Numaguchi T, Chihama R, Takenaka Y, Sato Y PLoS One. 2023; 18(8):e0273604.

PMID: 37556447 PMC: 10411811. DOI: 10.1371/journal.pone.0273604.

Can Probiotics, Particularly UCO-979C and UCO-25A, Be Preventive Alternatives against SARS-CoV-2?.

Valdebenito-Navarrete H, Fuentes-Barrera V, Smith C, Salas-Burgos A, A Zuniga F, Gomez L Biology (Basel). 2023; 12(3).

PMID: 36979076 PMC: 10045641. DOI: 10.3390/biology12030384.

Pharmacological Efficacy of Probiotics in Respiratory Viral Infections: A Comprehensive Review.

Wahab S, Almaghaslah D, Mahmood S, Ahmad M, Alsayegh A, Abu Haddash Y J Pers Med. 2022; 12(8).

PMID: 36013241 PMC: 9409792. DOI: 10.3390/jpm12081292.

References

Aso Y, Akazan H . Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group. Urol Int. 1992; 49(3):125-9. DOI: 10.1159/000282409. View

Eichelberger M . Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J Virol. 1995; 69(10):6359-66. PMC: 189535. DOI: 10.1128/JVI.69.10.6359-6366.1995. View

Dong L, Mori I, Hossain M, Kimura Y . The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J Infect Dis. 2000; 182(2):391-6. DOI: 10.1086/315727. View

Yasui H, Kiyoshima J, Hori T, Shida K . Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064. Clin Diagn Lab Immunol. 1999; 6(2):186-92. PMC: 95685. DOI: 10.1128/CDLI.6.2.186-192.1999. View

Allan W, Tabi Z, Cleary A, Doherty P . Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J Immunol. 1990; 144(10):3980-6. View

Webster R, Askonas B . Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol. 1980; 10(5):396-401. DOI: 10.1002/eji.1830100515. View

Mitchell D, McMichael A, Lamb J . The immunology of influenza. Br Med Bull. 1985; 41(1):80-5. DOI: 10.1093/oxfordjournals.bmb.a072031. View

Del Gobbo V, Villani N, Marini S, Balestra E, Calio R . Suppressor cells induced by influenza virus inhibit interleukin-2 production in mice. Immunology. 1990; 69(3):454-9. PMC: 1385967. View

Gilliland S . Acidophilus milk products: a review of potential benefits to consumers. J Dairy Sci. 1989; 72(10):2483-94. DOI: 10.3168/jds.S0022-0302(89)79389-9. View

10.

Nagao F, Nakayama M, Muto T, Okumura K . Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem. 2001; 64(12):2706-8. DOI: 10.1271/bbb.64.2706. View

11.

Watanabe T, Saito H . Protection of mice against herpes simplex virus infection by a Lactobacillus casei preparation (LC 9018) in combination with inactivated viral antigen. Microbiol Immunol. 1986; 30(2):111-22. DOI: 10.1111/j.1348-0421.1986.tb00926.x. View

12.

Santoro M, Favalli C, Mastino A, Jaffe B, Esteban M, Garaci E . Antiviral activity of a synthetic analog of prostaglandin A in mice infected with influenza A virus. Arch Virol. 1988; 99(1-2):89-100. DOI: 10.1007/BF01311026. View

13.

Yasui H, Shida K, Matsuzaki T, Yokokura T . Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek. 1999; 76(1-4):383-9. View

14.

Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T . Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis. 2001; 22(4):599-605. DOI: 10.1093/carcin/22.4.599. View

15.

Kato I, Tanaka K, Yokokura T . Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes. Int J Immunopharmacol. 1999; 21(2):121-31. DOI: 10.1016/s0192-0561(98)00072-1. View

16.

Shida K, Makino K, Morishita A, Takamizawa K, Hachimura S, Ametani A . Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int Arch Allergy Immunol. 1998; 115(4):278-87. DOI: 10.1159/000069458. View

17.

Tamura S, Asanuma H, Ito Y, Hirabayashi Y, Suzuki Y, Nagamine T . Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur J Immunol. 1992; 22(2):477-81. DOI: 10.1002/eji.1830220228. View

18.

Matsuzaki T . Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int J Food Microbiol. 1998; 41(2):133-40. DOI: 10.1016/s0168-1605(98)00046-4. View

19.

Glezen W, Payne A, Snyder D, Downs T . Mortality and influenza. J Infect Dis. 1982; 146(3):313-21. DOI: 10.1093/infdis/146.3.313. View

20.

Hori T, Kiyoshima J, Shida K, Yasui H . Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice. Clin Diagn Lab Immunol. 2001; 8(3):593-7. PMC: 96107. DOI: 10.1128/CDLI.8.3.593-597.2001. View